Document ID: chunk:federal_register_of_legislation:F2025C00124:front:0:p1
Version: federal_register_of_legislation:F2025C00124
Segment Type: other
Provision Reference: 
Character Range: 0–3078

National Health (Highly Specialised Drugs Program) Special Arrangement 2021

PB 27 of 2021
made under sections 85, 85A, 88, 99 and 100 of the

National Health Act 1953

Compilation No. 47

Compilation date: 1 February 2025

Includes amendments: F2025L00066

About this compilation

This compilation

This is a compilation of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 that shows the text of the law as amended and in force on 1 February 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents
Part 1—Preliminary
Division 1—General
1 Name
3 Authority
5 Simplified outline of this instrument
6 Definitions
7 Definition of authorised prescriber
8 Definition of eligible patient
Division 2—Supplies of HSD pharmaceutical benefits from hospitals
9 Supplies of HSD pharmaceutical benefits by approved hospital authorities to patients receiving treatment from hospitals
Division 3—HSD hospital authorities
10 HSD hospital authorities
11 References to approved suppliers and approved hospital authorities
12 Numbers allotted to HSD hospital authorities
Part 2—Special arrangement supplies of HSD pharmaceutical benefits
Division 1—Preliminary
13 Definition of special arrangement supply
Division 2—Prescribing of HSD pharmaceutical benefits
15 Prescription circumstances—general (Act s 85(7)(a) and (b))
16 Prescription circumstances—authority required procedures
18 When medication chart prescriptions not to be written
19 Prescriptions not to direct repeated supplies for visitors to Australia
20 Maximum quantity or number of units (Act s 85A(2)(a))
21 Maximum number of repeats (Act